General MedicationsORALGeneric
GANTANOL
SULFAMETHOXAZOLE
Standard Dose
500MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview GANTANOL is listed in Drugs@FDA under application 012715 (NDA).
Marketing status: Discontinued Active ingredient SULFAMETHOXAZOLE Form and strength TABLET;ORAL - 500MG Sponsor ROCHE Submission history Latest submission status date: 2001-09-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview GANTANOL is listed in Drugs@FDA under application 012715 (NDA). Marketing status: Discontinued Active ingredient SULFAMETHOXAZOLE Form and strength TABLET;ORAL - 500MG Sponsor ROCHE Submission history Latest submission status date: 2001-09-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.